LILRB2 promotes immune escape in breast cancer cells via enhanced HLA-A degradation.
Jiang Z, Huang Q, Chang Y, Qiu Y, Cheng H, Yang M, Ruan S, Ji S, Sun J, Wang Z, Xu S, Liang R, Dai X, Wu K, Li B, Li D, Zhao H.
Jiang Z, et al. Among authors: ruan s.
Cell Oncol (Dordr). 2024 Apr 24. doi: 10.1007/s13402-024-00947-5. Online ahead of print.
Cell Oncol (Dordr). 2024.
PMID: 38656573